Francois Pierre Combes (François Pierre Combes)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Tyrosine Kinase

Extracorporeal Membrane Oxygenation

Top Venues

Clinical pharmacokinetics

Journal of pharmacokinetics and pharmacodynamics

Clinical pharmacology and therapeutics

Novartis Pharmaceuticals Corporation

University Paris Diderot (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Pharmaceuticals Corporation Feb 08 2016

United States

Principal pharmacometrics :: Pharmacometrics

University of florida Apr 01 2014 - Jan 30 2016

United States

Postdoctoral Research Associate :: center for pharmacometrics and systems pharmacology

Education History

University Paris Diderot Jan 01 2011 - Mar 31 2014

France

PHD :: UMR 738 models and methods for therapeutic evaluation in chronic diseases

Publications

Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li, Sebastien Lorenzo, Kohinoor Dasgupta, Shruti Kapoor, Matthias Hoch, Yu-Yun Ho
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation. Clinical pharmacokinetics (2024)
Francois Pierre Combes, Ying Fei Li, Matthias Hoch, Sebastien Lorenzo, Yu-Yun Ho, Sherwin K B Sy
Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Clinical pharmacology and therapeutics 112 (5) (2022)
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, Sebastien Lorenzo, Sherwin K B Sy, Yu-Yun Ho
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases. Clinical pharmacokinetics 61 (10) (2022)
Francois Pierre Combes, Guillaume Baneyx, Neva Coello, Penny Zhu, William Sallas, Hequn Yin, Jerry Nedelman
Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex. Journal of pharmacokinetics and pharmacodynamics 45 (5) (2018)